Clinical trials recruiting for Hemoglobinopathies
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Alemtuzumab | 1 |
| Busulfan | 1 |
| CTX001 | 1 |
| Cell Infusion | 1 |
| Cyclophosphamide | 1 |
| Fludarabine | 1 |
| GVHD prophylaxis regimen | 1 |
| GWAS | 1 |
| Mycophenolate Mofetil | 1 |
| Plerixafor (mozobil) | 1 |
| RIC regimen | 1 |
| Sirolimus | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Connecticut | 1 |
| Delaware | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| New York | 1 |
| North Carolina | 1 |
| Tennessee | 1 |
Top cities
Self-screener
Recruiting trials
- Allo HSCT for High Risk Hemoglobinopathies
- Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
- Study of the Role of Genetic Modifiers in Hemoglobinopathies
Related conditions
Trials recruiting for Hemoglobinopathies often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Hemoglobinopathies trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.